Article

Dr. Dana named MEEI director of cornea, refractive surgery

Boston-The Massachusetts Eye and Ear Infirmary (MEEI) appointed Reza Dana, MD, MSc, MPH, of Cambridge, MA, as director of its cornea and refractive surgery service. Dr. Dana has been an associate surgeon at MEEI since 2001 and has served as acting director of the cornea and refractive surgery service since April.

He is an associate professor and senior scientist at Harvard Medical School and specializes in the cornea and external diseases, ocular inflammation and uveitis, and corneal transplantation.

Dr. Dana received a doctor of medicine and a master of public health degree from Johns Hopkins University and completed his residency at the Illinois Eye and Ear Infirmary. In addition, he completed fellowships in both cornea and external diseases, and immunology and uveitis, at the Wills Eye Hospital and MEEI, respectively. Dr. Dana also holds a master's degree in healthcare management from Harvard University.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.